TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.

Saved in:
Bibliographic Details
Title: TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members.
Authors: Delahunty R; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Nguyen L; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Craig S; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Creighton B; Ovarian Cancer Australia, Melbourne, Victoria, Australia., Ariyaratne D; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Garsed DW; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Christie E; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Fereday S; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Andrews L; Prince of Wales Hospital, Randwick, New South Wales, Australia.; Royal Hospital for Women, Randwick, New South Wales Australia., Lewis A; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Parkville, Victoria, Australia., Limb S; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Parkville, Victoria, Australia., Pandey A; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Hendley J; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Traficante N; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Carvajal N; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Spurdle AB; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Thompson B; Department of Pathology, Royal Melbourne Hospital, Parkville, Victoria, Australia.; Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia., Parsons MT; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Beshay V; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Volcheck M; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; The Royal Women's Hospital, Melbourne Victoria, Australia.; The Royal Children's Hospital, Melbourne Victoria, Australia., Semple T; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Lupat R; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Doig K; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Yu J; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Chen XQ; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Marsh A; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Love C; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia., Bilic S; Department of Gynecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia., Beilin M; Department of Gynecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia., Nichols CB; Genetic Services of Western Australia, Perth, Western Australia, Australia., Greer C; Genetic Services of Western Australia, Perth, Western Australia, Australia., Lee YC; Prince of Wales Hospital, Randwick, New South Wales, Australia.; Royal Hospital for Women, Randwick, New South Wales Australia.; Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia., Gerty S; Prince of Wales Hospital, Randwick, New South Wales, Australia., Gill L; Prince of Wales Hospital, Randwick, New South Wales, Australia., Newton E; Prince of Wales Hospital, Randwick, New South Wales, Australia., Howard J; Prince of Wales Hospital, Randwick, New South Wales, Australia., Williams R; Prince of Wales Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.; Prince of Wales Hereditary Cancer Centre, Prince of Wales Hospital Randwick, New South Wales, Australia., Norris C; Prince of Wales Hospital, Randwick, New South Wales, Australia., Stephens AN; Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, Australia.; School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia., Tutty E; Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Parkville, Victoria, Australia., Smyth C; Monash Health Familial Cancer Centre, Clayton, Victoria, Australia., O'Connell S; Monash Health Familial Cancer Centre, Clayton, Victoria, Australia., Jobling T; Monash Health, Bentleigh East, Melbourne, Australia., Stewart CJR; PathWest, King Edward Memorial Hospital, Subiaco, Western Australia, Australia., Tan A; Clinipath Pathology, Osborne Park, Western Australia, Australia., Fox SB; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Pachter N; Genetic Services of Western Australia, Perth, Western Australia, Australia.; King Edward Memorial Hospital, Perth, Western Australia, Australia.; Faculty of Health and Medical Sciences, University of Western Australia, Perth Australia., Li J; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Ellul J; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Mir Arnau G; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Young MA; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research Darlinghurst, New South Wales, Australia., Gordon L; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.; School of Nursing, Queensland University of Technology, Brisbane, Queensland, Australia., Forrest L; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Harris M; Monash Health, Bentleigh East, Melbourne, Australia., Livingstone K; Consumer Advocate, Melbourne, Victoria, Australia., Hill J; Ovarian Cancer Australia, Melbourne, Victoria, Australia., Chenevix-Trench G; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Cohen PA; Department of Gynecological Oncology, St John of God Hospital, Subiaco, Western Australia, Australia.; Division of Obstetrics and Gynaecology, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia., Webb PM; QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia., Friedlander M; Prince of Wales Hospital, Randwick, New South Wales, Australia.; Royal Hospital for Women, Randwick, New South Wales Australia.; Genetic Services of Western Australia, Perth, Western Australia, Australia., James P; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Bowtell D; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia., Alsop K; Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
Corporate Authors: Australian Ovarian Cancer Study, Ovarian Cancer Prognosis and Lifestyle Study and the TRACEBACK Study
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jun 20; Vol. 40 (18), pp. 2036-2047. Date of Electronic Publication: 2022 Mar 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.21.02108